L. M. Buckmiller, G. T. Richter, M. Waner and J. Y. Suen, “Use of Recombinant Factor VIIa during Excision of Vascular Anomalies,” Laryngoscope, Vol. 117, No. 4, 2007, pp. 604-609. doi:10.1097/MLG.0b013e318030450e

has been cited by the following article:

• TITLE: Use of the LigaSureTM in Cervicofacial Venous Malformation Excision

  AUTHORS: Eri Konno, Emi Ochi, Hisao Ogata, Kazuo Kishi

  KEYWORDS: Venous Malformations (VMs); LigaSureTM; Vessel Sealing System; Postoperative Bleeding

  JOURNAL NAME: Modern Plastic Surgery, Vol.3 No.3, July 5, 2013

  ABSTRACT: Complete surgical excision of venous malformations (VMs) is frequently complicated by massive bleeding and nerve damage, particularly in the cervicofacial area. This report describes a novel technique for the resection of cervicofacial VMs using the LigaSureTM (Valleylab, Tyco International Healthcare, Boulder, CO) vessel sealing system. We report three cases of VM excision using this vessel sealing system, and recorded intraoperative and postoperative blood loss, operative time, and postoperative complications. In all cases employing the LigasureTM, perioperative blood loss was less than 600 ml, no patients developed postoperative hematomas or other bleeding complications, and no patients developed a facial palsy even if the VM was located close to the facial nerve. LigaSureTM provides excellent hemostasis with few complications when used for cervicofacial VMs.